| John Crary, MD | |
|
630 West 168th St, Ph 1564w, Ny, NY 10032 | |
| (212) 305-7399 | |
| Not Available |
| Full Name | John Crary |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 18 Years |
| Location | 630 West 168th St, Ny, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942469895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 250342 (New York) | Primary |
| 207ZN0500X | Pathology - Neuropathology | 250342 (New York) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
In chronic obstructive pulmonary disease (COPD), the patients' lungs lose their ability to repair damages on their own.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
While the most prevalent focus of February is on Valentine's sweethearts, parents are well advised to also focus on the proverbial sweet tooth - particularly when it comes to their children. That's because February is National Children's Dental Health Month, an ideal time - according to Health Net, Inc. - for moms and dads to make sure that sugary snacks, as well as lax dental hygiene - aren't putting their kids at risk for tooth decay.
Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.
› Verified 8 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104162700 PECOS PAC ID: 2264691070 Enrollment ID: O20130601000000 |
News Archive
In chronic obstructive pulmonary disease (COPD), the patients' lungs lose their ability to repair damages on their own.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
While the most prevalent focus of February is on Valentine's sweethearts, parents are well advised to also focus on the proverbial sweet tooth - particularly when it comes to their children. That's because February is National Children's Dental Health Month, an ideal time - according to Health Net, Inc. - for moms and dads to make sure that sugary snacks, as well as lax dental hygiene - aren't putting their kids at risk for tooth decay.
Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.
› Verified 8 days ago
| Entity Name | Fpa Hospital Based |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629319413 PECOS PAC ID: 4789826694 Enrollment ID: O20130806000185 |
News Archive
In chronic obstructive pulmonary disease (COPD), the patients' lungs lose their ability to repair damages on their own.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
While the most prevalent focus of February is on Valentine's sweethearts, parents are well advised to also focus on the proverbial sweet tooth - particularly when it comes to their children. That's because February is National Children's Dental Health Month, an ideal time - according to Health Net, Inc. - for moms and dads to make sure that sugary snacks, as well as lax dental hygiene - aren't putting their kids at risk for tooth decay.
Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Crary, MD 630 West 168th St, Ph 1564w, Ny, NY 10032 Ph: (212) 305-7399 | John Crary, MD 630 West 168th St, Ph 1564w, Ny, NY 10032 Ph: (212) 305-7399 |
News Archive
In chronic obstructive pulmonary disease (COPD), the patients' lungs lose their ability to repair damages on their own.
ZIOPHARM Oncology, Inc. today announced the initiation of the pivotal Phase III clinical trial for palifosfamide in patients with front-line metastatic soft tissue sarcoma. The study, called PICASSO 3, is an international, randomized, double-blinded, placebo-controlled trial designed to enroll approximately 424 patients with metastatic soft tissue sarcoma who have never been treated with chemotherapy for metastatic disease.
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
While the most prevalent focus of February is on Valentine's sweethearts, parents are well advised to also focus on the proverbial sweet tooth - particularly when it comes to their children. That's because February is National Children's Dental Health Month, an ideal time - according to Health Net, Inc. - for moms and dads to make sure that sugary snacks, as well as lax dental hygiene - aren't putting their kids at risk for tooth decay.
Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.
› Verified 8 days ago
Stephen Lagana, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 630 West 168th St Ph 1564w, Ny, NY 10032 Phone: 212-305-7399 | |
Dr. Mehrvash Haghighi, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 622 West 168th St. Ph 1564w, Ny, NY 10032 Phone: 212-305-7399 | |
Yvette Tanhehco, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 630 West 168th St, Ph 1564w, Ny, NY 10032 Phone: 212-305-7399 | |
Dr. Patricia G Tiscornia-wasserman, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 630 West 168th St Ph 1564w, Ny, NY 10032 Phone: 212-305-7399 Fax: 718-347-4866 | |
Dr. Xiaowei Chen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 630 West 168th St P & S 16-404, Ny, NY 10032 Phone: 718-918-3060 Fax: 718-918-4469 | |
Xiaolin Liu-jarin, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 630 West 168th St, Ny, NY 10032 Phone: 212-305-7399 Fax: 201-462-4706 | |
Hui Min Yang, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 622 West 168th St Ph1564w, Ny, NY 10032 Phone: 212-305-7399 |